IGF2R and metabolic syndrome: Moreover, compared to controls, significantly elevated MiR-143-3p levels in serum and urine have been found in patients with metabolic syndrome, with the insulin-like growth factor 2 receptor (IGF2R) gene being among the target genes of MiR-143-3p [157].